Home 
Bratislava Medical Journal Ahead of print Bratislava Medical Journal Vol.124, No.6, p.417–420, 2023
Bratislava Medical Journal Ahead of print Bratislava Medical Journal Vol.124, No.6, p.417–420, 2023
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.124, No.6, p.417–420, 2023 |
||
| Title: Autovaccines – potent tool against chronic vulvovaginal candidiasis | ||
| Author: Jan KOREN, Magdalena ZABORSKA, Ivan VARGA, Jozef ZAHUMENSKY, Adriana LIPTAKOVA | ||
| Abstract: OBJECTIVE: Our aim was to determine the effect of immunomodulatory therapy in women with chronic and recurrent vulvovaginal candidiasis (RVVC). BACKGROUND: We present recent highlights in the research into vaginal microbiome and consequences of chronic inflammation such as vulvovaginal candidiasis (VVC). VVC is a widespread vaginal infection primarily caused by Candida albicans. Experience of more than three episodes per year is defined as RVVC. METHODS: The strains were isolated from women suffering from the above infections as for the period of 2017 to 2021 and subsequently used in immunomodulatory treatment. The preparation and administration of autovaccination therapy was performed using standard methodology and procedures cited in the manuscript. RESULTS: In total, autovaccines were produced for 73 patients of whom 30 (41 %) were successfully cured by this treatment, 29 (40 %) experienced a partially successful treatment, and in the remaining 14 (19 %), the autovaccination therapy was ineffective. CONCLUSION: We provide current knowledge about alternative (autovaccine) treatment options for female patients with VVC and RVVC diseases and our experience with the outcomes after autovaccine administration that currently has a promising therapeutic potential (Tab. 2, Ref. 18). Text in PDF www.elis.sk |
||
| Keywords: autovaccines, chronic infections, vulvovaginal candidiasis, recurrent, Candida albicans | ||
| Published online: 28-Feb-2023 | ||
| Year: 2023, Volume: 124, Issue: 6 | Page From: 417, Page To: 420 | |
| doi:10.4149/BLL_2023_063 |
||
|
|
 download file |
|